Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy
Carol M. Amato(Florence (Netherlands)), William A. Robinson(University of Colorado Anschutz Medical Campus)
Cited by 75
Related Papers
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa
|Science Translational Medicine|2018|132
Interferon α-2a and Dacarbazine in Melanoma
|JNCI Journal of the National Cancer Institute|1990|47
Circulating CD8 <sup>+</sup> mucosal‐associated invariant T cells correlate with improved treatment responses and overall survival in anti‐PD‐1‐treated melanoma patients
|Clinical & Translational Immunology|2022|26